Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial

Published:2004 Issue:6 Volume:50 Page:1939-1950
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Kaltwasser J. Peter,Nash Peter,Gladman Dafna,Rosen Cheryl F.,Behrens Frank,Jones Peter,Wollenhaupt J�rgen,Falk Franziska G.,Mease Philip,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference47 articles.

1. PSORIATIC ARTHRITIS IN PSORIATIC PATIENTS

2. Skin lesions in psoriasis

3. National Psoriasis Foundation. New research shows 1 million U.S. adults suffer from psoriatic arthritis: others may be at risk but not know it. Portland (OR): NPF Press Releases; May 15, 2002. URL: http://www.psoriasis.org/release2002.psasurvey.htm.

Cited by 342 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is JAK inhibitor the option to prevent difficult‐to‐manage axial spondyloarthritis?;International Journal of Rheumatic Diseases;2024-09

2. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

3. Efficacy of Leflunomide Compared to Methotrexate in the Treatment of Moderate to Severe Plaques Psoriasis: A Randomized Controlled Clinical Trial;Dermatology Practical & Conceptual;2024-07-31

4. Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis;The Journal of Rheumatology;2024-04-01

5. Psoriasis and Related Disorders;Rook's Textbook of Dermatology;2024-03-19